ライフサイエンスコーパス: platelet-derived growth factor

1 ascular endothelial growth factor) and PDGF (platelet derived growth factor).

2 CCN2 (connective tissue growth factor), and platelet-derived growth factor.

3 ascular endothelial growth factor (VEGF) and platelet-derived growth factor.

4 wing stimulation with interleukin-1alpha and platelet-derived growth factor.

5 rbor an activating mutation in either KIT or platelet-derived growth factor A ( PDGFRA).

6 r receptor alpha (PDGFRalpha) and its ligand platelet-derived growth factor A (PDGF-A) are co-express

7 In addition, platelet-derived growth factor A (PDGFA) was overexpress

8 n activating gene mutations in either KIT or platelet-derived growth factor A (PDGFRA).

9 The membrane-bound receptor for platelet-derived growth factor A (PDGFRalpha) is crucial

10 We report a novel association of MUC1 with platelet-derived growth factor-A (PDGFA).

11 ast differentiation through the secretion of platelet-derived growth factor AA (PDGF-AA).

12 s (angiopoietin 2; hepatocyte growth factor; platelet-derived growth factor AA and BB; placental grow

13 Intravitreal injection of platelet-derived growth factor -AA or -AB led to profoun

14 broblasts exhibit impaired responsiveness to platelet-derived growth factor-AA and sonic hedgehog, tw

15 tumor necrosis factor alpha (TNF-alpha), and platelet-derived growth factor-AA, also were elevated si

16 tor, vascular endothelial growth factor, and platelet-derived growth factor AB) before and after comp

17 line lung/liver SUVmax index correlated with platelet-derived growth factor AB.

18 e Boyden chamber and show that a gradient of platelet-derived growth factor-AB (PDGF-AB) expedites mi

19 sient treatment with AZA in combination with platelet-derived growth factor-AB converts primary somat

20 scular smooth muscle cells (VSMCs), that the platelet-derived growth factor activates canonical store

21 ch-clamp recordings showed that although the platelet-derived growth factor activates the canonical C

22 Platelet-derived growth factor alpha (PDGFA) is frequent

23 These cells expressed platelet-derived growth factor alpha and high transcript

24 1, and transiently suppressed myofibroblast platelet-derived growth factor alpha differentiation mar

25 a similar level of TNF-alpha, TGF-beta1, and platelet-derived growth factor alpha genes, and a high l

26 recursor activity in embryos was confined to platelet-derived growth factor alpha(+), myogenic factor

27 cts with HEUS and in untreated subjects with platelet-derived growth factor alpha-negative HES (n = 2

28 which also express collagen 1a1, desmin and platelet-derived growth factor (alpha polypeptide) but n

29 ynthesis, which required the late release of platelet-derived growth factor and COX-2 mRNA stabilizat

30 ffect on vascular endothelial growth factor, platelet-derived growth factor and KIT receptors in pati

31 Platelet-rich plasma (PRP) consists of platelet-derived growth factor and transforming growth f

32 standard care and low-strength evidence for platelet-derived growth factors and silver cream compare

33 proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent prote

34 d non-responders including stem cell factor, platelet-derived growth factor, and interleukin-15.

35 g-pressure surfaces, hydrocolloid dressings, platelet-derived growth factor, and light therapy improv

36 flammatory cytokines, invade Matrigel toward platelet-derived growth factor, and resist hypoxia-induc

37 th factors, such as epidermal growth factor, platelet-derived growth factor, and Wnt; and hormones, s

38 o mediate the secretion of Pvf, a ligand for platelet-derived growth factor- and vascular endothelial

39 ice, including interleukin-1beta (IL-1beta), platelet-derived growth factor, angiopoietin 2, insulin-

40 such as transforming growth factor-beta and platelet-derived growth factor, as well as profibrotic p

41 n fibrotic lungs was driven by expression of platelet-derived growth factor B (PDGF-B) in lymphatic e

42 Because platelet-derived growth factor B (PDGF-B) signaling has

43 direct transactivation of the gene encoding platelet-derived growth factor B (PDGF-B), which has pro

44 morphogen sonic hedgehog (Shh) is driven by platelet-derived growth factor B (PDGF-BB) in vascular s

45 ar endothelial growth factor A (VEGF-A), and platelet-derived growth factor B chain (PDGF-BB), to sti

46 ngiopoietin-like 4, placental growth factor, platelet-derived growth factor B, stem cell factor (kit

47 nd AKT and compared them to oligodendroglial platelet-derived growth factor B-induced tumors in Ctv-a

48 h, we demonstrate that two of these pathways-platelet-derived growth factor BB (PDGF BB) and neural p

49 We first identified Shh as a target of platelet-derived growth factor BB (PDGF-BB) and found th

50 ed a fibronectin peptide (P12) that can bind platelet-derived growth factor BB (PDGF-BB) and promote

51 Growth factors, such as platelet-derived growth factor BB (PDGF-BB) and transfor

52 ulated by ECFC-derived paracrine factors via platelet-derived growth factor BB (PDGF-BB)/platelet-der

53 study participants, the angiogenic cytokine platelet-derived growth factor BB glycoprotein correlate

54 Two weeks after AMI, increased PB platelet-derived growth factor BB glycoprotein was assoc

55 are recruited to developing blood vessels by platelet-derived growth factor BB, support endothelial c

56 ession of the spliced XBP1 or treatment with platelet derived growth factor-BB up-regulated miR-150 e

57 tors such as tumor necrosis factor-alpha and platelet derived growth factor-BB were also found to inc

58 Platelet-derived growth factor-BB (PDGF)-induced prolife

59 ), which when tethered to a surface acted as platelet-derived growth factor-BB (PDGF-BB) enhancers to

60 Here, we found that platelet-derived growth factor-BB (PDGF-BB) secreted by

61 sforming growth factor-alpha (TGF-alpha) and platelet-derived growth factor-BB (PDGF-BB) were reduced

62 the receptor tyrosine kinase (RTK) agonist, platelet-derived growth factor-BB (PDGF-BB)-induced p21C

63 rom the culture of fat with ROS or PGZ on i) platelet-derived growth factor-BB (PDGF-BB)-stimulated p

64 tematic review, the use of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) led to gre

65 atrix derivative (EMD) and recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with beta-

66 e graft (CTG) (control) or recombinant human platelet-derived growth factor-BB + beta-tricalcium phos

67 tor-2, transforming growth factor-beta1, and platelet-derived growth factor-BB at 2 weeks compared wi

68 gration and fibronectin synthesis induced by platelet-derived growth factor-BB or TGF-beta2.

69 amel matrix derivative and recombinant human platelet-derived growth factor-BB plus beta-tricalcium p

70 s 200 ng of bone morphogenetic protein-2 and platelet-derived growth factor-BB that were eluted over

71 growth factor, interleukin 6, angiopoietin, platelet-derived growth factor-BB, placental growth fact

72 matory cytokines interferon gamma, IL-1, and platelet-derived growth factor-BB, which are not produce

73 ion post-TBI required megakaryocyte-secreted platelet-derived growth factor-BB.

74 (VWF), glutathione peroxidase 3 (GPX3), and platelet-derived growth factor beta (PDGFB).

75 e phosphorylated in the presence of EGFR and platelet-derived growth factor beta receptor (PDGFbetaR)

76 nds to the transmembrane domain (TMD) of the platelet-derived growth factor beta receptor (PDGFbetaR)

77 d cells by forming a stable complex with the platelet-derived growth factor beta receptor transmembra

78 nteract with the transmembrane domain of the platelet-derived growth factor beta-receptor and specifi

79 Platelet-derived growth factor-beta (PDGFB) is a mitogen

80 despite constituting a small fraction of the platelet-derived growth factor-beta (PDGFRbeta)(+) cell

81 nsforming growth factor-beta [TGF-beta], and platelet-derived growth factor-beta [PDGF-beta]) and blo

82 pe I collagen, matrix metalloprotease-1, and platelet-derived growth factor-beta.

83 on and migration of human aortic SMCs toward platelet-derived growth factor by inhibiting, in a ghrel

84 Intracerebral injection of platelet-derived growth factor-CC (PDGF-CC), which incre

85 fibroblast haptotaxis on fibronectin but not platelet-derived growth factor chemotaxis.

86 odeling linked to maximal thrombospondin and platelet-derived growth factor D expression.

87 phages, T cells, and platelets and increased platelet-derived growth factor D, Pdgfrb, Itga2, and mat

88 ein oxidation within cells, and suggest that platelet-derived growth factor-dependent "redoxosomes,"

89 es insight into the vascular architecture of platelet-derived growth factor-driven glioblastoma.

90 Platelet-derived growth factor, estrogen, and serotonin

91 We find that platelet-derived growth factor evokes transient oxidatio

92 cell neuroprotection, with factors from the platelet-derived growth factor family being the most pot

93 f activated T cells, epidermal growth factor/platelet-derived growth factor family members, Wnt/beta-

94 Two of these loci flank the canine platelet-derived growth factor gene, which affects bone

95 ulture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on

96 on into brains of mice engineered to express platelet-derived growth factor in the central nervous sy

97 idence of and accelerated the development of platelet-derived growth factor -induced glioma in mice.

98 genetic deletion mutant in a mouse model of platelet-derived growth factor-induced malignant oligode

99 feedback circuit is likely to operate during platelet-derived growth factor-induced random cell migra

100 In vitro, RR6 inhibited platelet-derived growth factor-induced SMC proliferation

101 factor, vascular endothelial growth factor, platelet-derived growth factor, interleukin (IL)-8, IL-1

102 Furthermore, platelet-derived growth factor may represent an independ

103 The Platelet Derived Growth Factor (PDGF) family of ligands

104 Platelet derived growth factor (PDGF) plays a pivotal ro

105 cretion of numerous growth factors including platelet derived growth factor (PDGF).

106 Many signaling pathways, including platelet- derived growth factor (PDGF)-AA/alphaalpha, ar

107 Prostaglandin E2, platelet-derived growth factor (PDGF) AA, eotaxin, vascu

108 Platelet-derived growth factor (PDGF) acts through two c

109 ssion of other profibrotic cytokines such as platelet-derived growth factor (PDGF) and epidermal grow

110 to delineate the transcriptional response to platelet-derived growth factor (PDGF) and fibroblast gro

111 rum response factor (SRF) is induced by both platelet-derived growth factor (PDGF) and fibroblast gro

112 We find that fibroblasts treated with platelet-derived growth factor (PDGF) and prepolarized b

113 Expression of both platelet-derived growth factor (PDGF) and vascular endot

114 e involved in the lipopolysaccharide-induced platelet-derived growth factor (PDGF) and Wnt signaling

115 10030 (Fovista; Ophthotech, New York, NY), a platelet-derived growth factor (PDGF) antagonist, admini

116 Using these platforms, 10 pM platelet-derived growth factor (PDGF) are detected withi

117 ein that exists in a stable complex with the platelet-derived growth factor (PDGF) beta receptor, cau

118 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) family members are

119 Platelet-derived growth factor (PDGF) family members are

120 Growth factors such as platelet-derived growth factor (PDGF) have significantly

121 d apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for

122 Platelet-derived growth factor (PDGF) is a mitogen and c

123 rowth factors, the most representative being platelet-derived growth factor (PDGF) isoforms (PDGF-AA,

124 Certain platelet-derived growth factor (PDGF) isoforms are assoc

125 We also provided evidence that platelet-derived growth factor (PDGF) plays a substantia

126 ied KCE method to an experimental model of a platelet-derived growth factor (PDGF) protein and its DN

127 The platelet-derived growth factor (PDGF) receptor (PDGFR) f

128 While platelet-derived growth factor (PDGF) receptor alpha (PD

129 easing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor beta (bet

130 Platelet-derived growth factor (PDGF) receptor signaling

131 The platelet-derived growth factor (PDGF) receptors (PDGFRs)

132 Activation of the c-kit and platelet-derived growth factor (PDGF) receptors by autoc

133 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors, has sin

134 -of-function alterations leading to enhanced platelet-derived growth factor (PDGF) signaling are comm

135 Enhanced platelet-derived growth factor (PDGF) signaling in gliom

136 Inhibition of foxc1 perturbed platelet-derived growth factor (Pdgf) signaling, impairi

137 sine kinase that is activated in response to platelet-derived growth factor (PDGF) stimulation.

138 ng a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to allevi

139 Platelet-derived growth factor (PDGF), a potent mitogen

140 clotted wound by a concentration gradient of platelet-derived growth factor (PDGF), together with oth

141 In vitro platelet-derived growth factor (PDGF)- and tumor necrosi

142 escribe a novel gene expression signature of platelet-derived growth factor (PDGF)-activated fibrobla

143 blood vessel physiology and tissue fibrosis, platelet-derived growth factor (PDGF)-B and transforming

144 Here, we show that platelet-derived growth factor (PDGF)-B/PDGF receptor be

145 Platelet-derived growth factor (PDGF)-BB belongs to a fa

146 EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1

147 rotid artery, and VSMCs were pretreated with platelet-derived growth factor (PDGF)-BB.

148 angiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-beta, and phosphat

149 We have identified platelet-derived growth factor (PDGF)-CC as a potent pro

150 e discovery of a novel ligand for PDGFRbeta, platelet-derived growth factor (PDGF)-DD, opened the pos

151 Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes

152 d quiescent mesenchymal cell activation in a platelet-derived growth factor (PDGF)-dependent manner.

153 Here, we present two novel platelet-derived growth factor (PDGF)-driven mouse model

154 ells (HASMCs); effect of Sema3E on basal and platelet-derived growth factor (PDGF)-induced proliferat

155 In damaged retina of flies and mice, platelet-derived growth factor (PDGF)-like signaling ind

156 or small interfering RNA knockdown decreased platelet-derived growth factor (PDGF)-mediated migration

157 c chambers that generate stable gradients of platelet-derived growth factor (PDGF).

158 highly sensitive and selective detection of platelet-derived growth factor (PDGF).

159 ascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).

160 r (FGF)2, epidermal growth factor (EGF), and platelet-derived growth factor (PDGF).

161 are activated by the important growth factor platelet-derived growth factor (PDGF).

162 EC was uniformly inhibited by combined VEGF/platelet-derived growth factor (PDGF)/FGF receptor inhib

163 identified a specific RTK signaling pathway, platelet-derived growth factor (PDGF)/PDGF receptor (PDG

164 ular endothelial growth factor (VEGF) and 2) platelet-derived growth factor (PDGF-BB) in gingival cre

165 ignaling aptamer/protein binding complex for platelet-derived growth factor (PDGF-BB) oncoprotein det

166 rCS3 binds the nerve growth factor (NGF) and platelet-derived growth factor (PDGF-BB), but the functi

167 Platelet-derived growth factors (PDGF) are key mediators

168 Platelet-derived growth factors (PDGF) have an ambiguous

169 Platelet-derived growth factors (PDGFs) and their recept

170 ined-immunodeficient mice, (3) expression of platelet-derived growth factors (PDGFs) and their recept

171 veloped a simple method for the detection of platelet-derived growth factors (PDGFs) based on base st

172 scular endothelial growth factor A (VEGF-A), platelet-derived growth factors (PDGFs), and non-PDGFs (

173 d growth factor-related peptides and soluble platelet-derived growth factor-Ralpha were detected in a

174 factor], sCD40L [soluble CD40 ligand], PDGF [platelet-derived growth factor], RANTES [regulated on ac

175 PDGF signalling, through its receptor platelet derived growth factor receptor (PDGFR), is invo

176 Platelet derived growth factor receptor alpha (PDGFRalph

177 Interstitial cells, known as platelet derived growth factor receptor alpha (PDGFRalph

178 oma cells, including increased expression of platelet derived growth factor receptor beta (PDGFRB) me

179 ent of known imatinib targets including Abl, platelet derived growth factor receptor beta (PDGFRbeta)

180 ainst biomarkers, murine double minute 2 and platelet derived growth factor receptor.

181 rs of Colalpha1 (I), Colalpha2 (I), and beta-platelet-derived growth factor receptor (beta-Pdgfr) wit

182 Monitoring of anti-platelet-derived growth factor receptor (PDGF-R) antibod

183 razin-2(1H)-ones toward potent and effective platelet-derived growth factor receptor (PDGF-R) beta-in

184 ng fibroblast growth factor receptor (FGFR), platelet-derived growth factor receptor (PDGFR) and inte

185 nimals to determine the relationship between platelet-derived growth factor receptor (PDGFR) and sero

186 It activates platelet-derived growth factor receptor (PDGFR) beta in

187 st growth factor receptor (FGFR) family, the platelet-derived growth factor receptor (PDGFR) family,

188 Platelet-derived growth factor receptor (PDGFR) senses e

189 YR mice had significantly reduced amounts of platelet-derived growth factor receptor (PDGFR), which i

190 atic endothelial cells and signaling through platelet-derived growth factor receptor (PDGFR)-beta in

191 platelet-derived growth factor BB (PDGF-BB)/platelet-derived growth factor receptor (PDGFR)-beta sig

192 isib also inhibited ALL proliferation in ABL/platelet-derived growth factor receptor (PDGFR)-mutant m

193 l stromal tumor (GIST) cells overexpress the platelet-derived growth factor receptor (PDGFR)A, althou

194 Anterograde transport mutants display low platelet-derived growth factor receptor (PDGFR)alpha lev

195 othelial growth factor receptor (VEGFR)2 and platelet-derived growth factor receptor (PDGFR)alpha.

196 Nkx2.2 can directly bind to the promoter of platelet-derived growth factor receptor alpha (Pdgfra) a

197 GG), often in association with TP53 loss and platelet-derived growth factor receptor alpha (PDGFRA) a

198 opy number imbalances previously showed that platelet-derived growth factor receptor alpha (PDGFRA) i

199 We found that only platelet-derived growth factor receptor alpha (pdgfra) i

200 Here, we show an essential role for platelet-derived growth factor receptor alpha (Pdgfra) i

201 -oncogene receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor alpha (PDGFRA) m

202 errations in FLT3, tyrosine kinase 2 (TYK2), platelet-derived growth factor receptor alpha (PDGFRA),

203 Here, we show that platelet-derived growth factor receptor alpha (PDGFRalph

204 Platelet-derived growth factor receptor alpha (PDGFRalph

205 many different signaling pathways, including platelet-derived growth factor receptor alpha (PDGFRalph

206 Platelet-derived growth factor receptor alpha (PDGFRalph

207 Platelet-derived growth factor receptor alpha (PDGFRalph

208 Here we report that platelet-derived growth factor receptor alpha (PDGFRalph

209 In this study, we isolated Platelet-derived growth factor receptor alpha (PDGFRalph

210 ellular origin of new myelin by fate mapping platelet-derived growth factor receptor alpha (PDGFRalph

211 a poor prognosis and exhibit an increase in platelet-derived growth factor receptor alpha (PDGFRalph

212 Platelet-derived growth factor receptor alpha (PDGFRalph

213 that TAg expression reduces the abundance of platelet-derived growth factor receptor alpha (PDGFRalph

214 VEGF enhanced the viability of platelet-derived growth factor receptor alpha (PDGFRalph

215 ssed in primitive stromal cells that express platelet-derived growth factor receptor alpha and Sca-1

216 The KIT protooncogene or, less frequently, platelet-derived growth factor receptor alpha is mutated

217 SMCs), interstitial cells of Cajal (ICC) and platelet-derived growth factor receptor alpha positive (

218 Platelet-derived growth factor receptor alpha positive (

219 more, oncogenic RAB35 is sufficient to drive platelet-derived growth factor receptor alpha to LAMP2-p

220 ating with an increase in Il-6 expression in platelet-derived growth factor receptor alpha(+) mesench

221 differentiated alpha-smooth muscle actin(+)/platelet-derived growth factor receptor alpha(+)/CD44(+)

222 racterized by activating mutations of KIT or platelet-derived growth factor receptor alpha(PDGFRA), w

223 roblast growth factor receptors 1 through 4, platelet-derived growth factor receptor alpha, RET, and

224 atrix by increasing nonmuscle myosin II- and platelet-derived growth factor receptor alpha-mediated c

225 ntramuscular interstitial cells of Cajal and platelet-derived growth factor receptor alpha-positive c

226 ribution to vitreal bioactivity occurred via platelet-derived growth factor receptor alpha.

227 otes PVR by a noncanonical ability to engage platelet-derived growth factor receptor alpha.

228 press the mesenchymal stem cell (MSC) marker platelet-derived growth factor receptor alpha; hence, we

229 N, resulting in increased phosphorylation of platelet-derived growth factor receptor and activation o

230 (NOXs), and oxidized SHP2 co-localizes with platelet-derived growth factor receptor and NOX1/4.

231 factor receptor, heat shock protein 90, and platelet-derived growth factor receptor as well as mutua

232 ling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as bo

233 ranscriptional response to Mucorales reveals platelet-derived growth factor receptor B (PDGFRB) signa

234 ociated astrocytes expressing phosphorylated platelet-derived growth factor receptor beta (at tyrosin

235 ression and ligand-independent activation of platelet-derived growth factor receptor beta (Pdgfr-beta

236 n profiling, which revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) an

237 germline mutation c.1681C>T (p.Arg561Cys) in platelet-derived growth factor receptor beta (PDGFRB) in

238 protein Sestrin 2 (Sesn2) as a suppressor of platelet-derived growth factor receptor beta (Pdgfrbeta)

239 MEFs show slower kinetics of ligand-induced platelet-derived growth factor receptor beta (PDGFRbeta)

240 he overexpression and excessive signaling of platelet-derived growth factor receptor beta (PDGFRbeta)

241 We show that LOX activates Akt through platelet-derived growth factor receptor beta (PDGFRbeta)

242 hat imatinib, a tyrosine kinase inhibitor of platelet-derived growth factor receptor beta (PDGFRbeta)

243 Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRbeta)

244 Aberrant platelet-derived growth factor receptor beta (PDGFRbeta)

245 Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor beta and can cro

246 in 2 (IGFBP-2), nerve growth factor (b-NGF), platelet-derived growth factor receptor beta polypeptide

247 erved in a laser-induced model of CNV that a platelet-derived growth factor receptor beta positive (P

248 FDCs arise from perivascular platelet-derived growth factor receptor beta(+) precurso

249 gnificantly more NIK(+) ECs and perivascular platelet-derived growth factor receptor beta(+) preFDCs,

250 g., expression of alpha smooth muscle actin, platelet-derived growth factor receptor beta, desmin, vi

251 l665Ala variant in PDGFRB, which encodes the platelet-derived growth factor receptor beta.

252 structure provides a first glimpse into how platelet-derived growth factor receptor ECD, upon ligand

253 vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibitor PTK787

254 he vascular endothelial growth factor (VEGF)/platelet-derived growth factor receptor inhibitor suniti

255 ntibody or with small molecule inhibitors of platelet-derived growth factor receptor kinase or downst

256 Pathway analysis identified dysregulated platelet-derived growth factor receptor signaling in BPC

257 tivation by a receptor activation loop (from platelet-derived growth factor receptor, a receptor tyro

258 lial cells and interstitial cells expressing platelet-derived growth factor receptor, alpha polypepti

259 ced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met.

260 ion markers (alpha smooth muscle actin, beta platelet-derived growth factor receptor, and collagen I)

261 phosphorylated proangiogenic RTKs, including platelet-derived growth factor receptor, fibroblast grow

262 xpressing cells, nestin-expressing cells and platelet-derived growth factor receptor-alpha (PDGFR-alp

263 progenitors expressing a mesodermal marker, platelet-derived growth factor receptor-alpha (PDGFRA),

264 ell lines revealed co-activation of HER2 and platelet-derived growth factor receptor-alpha (PDGFRalph

265 opulation (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth factor receptor-alpha (PDGFRalph

266 could be identified with antibodies against platelet-derived growth factor receptor-alpha (PDGFRalph

267 Aberrant platelet-derived growth factor receptor-alpha (PDGFRalph

268 and flow sorted to isolate cells expressing platelet-derived growth factor receptor-alpha and exclud

269 ssion pattern, manifest in downregulation of platelet-derived growth factor receptor-alpha and recipr

270 to stabilize detrusor excitability involving platelet-derived growth factor receptor-alpha positive (

271 ild-type or constitutively activated PDGFRA (platelet-derived growth factor receptor-alpha) under con

272 tyrosine kinases (RTKs) such as PDGFRalpha (platelet-derived growth factor receptor-alpha), which sh

273 Senescent cells were positive for platelet-derived growth factor receptor-alpha, vimentin,

274 alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive a

275 y, 2) connective tissue progenitor cells, 3) platelet-derived growth factor receptor-alpha-positive c

276 Connective tissue progenitor cells, platelet-derived growth factor receptor-alpha-positive c

277 nd dendritic spine formation through Rabex-5/platelet-derived growth factor receptor-beta (PDGFRbeta)

278 y arterial muscularization via inhibition of platelet-derived growth factor receptor-beta on vascular

279 a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine

280 eoglycan NG2, a co-receptor of integrins and platelet-derived growth factor receptor.

281 Our results identify the Snail-PTEN platelet-derived growth factor receptor/phosphatidylinos

282 structure of PDGFRbeta [a full-length human platelet-derived growth factor receptor], in complex wit

283 Platelet-derived growth factor receptors (PDGFR) alpha a

284 inhibition of the Abelson kinase (c-Abl) and platelet-derived growth factor receptors (PDGFR) in expe

285 ne kinase activity of ABL1/BCR-ABL1 and KIT, platelet-derived growth factor receptors (PDGFRs), and t

286 Imatinib, a selective inhibitor of platelet-derived growth factor receptors, and anakinra,

287 Platelet-derived growth factor-related peptides and solu

288 ne (CM) with xenograft and recombinant human platelet-derived growth factor (rhPDGF) in guided bone r

289 Recombinant human platelet-derived growth factor (rhPDGF) is safe and effe

290 of neuroprotective proteins and suggest that platelet-derived growth factor secretion in particular m

291 By its inhibitory effect on platelet-derived growth factor signaling, imatinib could

292 -vascular endothelial growth factor and anti-platelet-derived growth factor signaling.

293 Blockade of platelet-derived growth factor signalling with neutraliz

294 Cortistatin inhibited platelet-derived growth factor-stimulated proliferation

295 ively regulate G1 progression in response to platelet-derived growth factor stimulation.

296 fically, we show how this transducer enables platelet-derived growth factor to trigger (in vitro) the

297 is a milieu of bioactive factors, including platelet derived growth factor, transforming growth fact

298 the hepatic stellate cell (HSC) activators, platelet-derived growth factor, transforming growth fact

299 SMILR was also altered by interleukin-1alpha/platelet-derived growth factor treatment, and HAS2 expre

300 ine kinase ligands (epidermal growth factor, platelet-derived growth factor, vascular endothelial gro